1,000 patients will receive free whole genome sequencing and interpretation, including personalized reports, thanks to Epilepsy Awareness Day at Disneyland, in a push to advance new research and gene therapies

Initiates Galactosemia Research Collaboration with Emory University School of Medicine

Synowledge is a global provider of drug safety, regulatory affairs and related IT solutions to small, mid and large sized pharmaceutical and biotechnology companies. Our comprehensive outsourcing solutions combine the unique strengths of both onshore

APFED, a patient advocacy organization representing eosinophilic disorders, to join NORD in observing Rare Disease Day 2012